Home › Trial NCT01634685
A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal Adenocarcinoma
- Trial IDNCT01634685
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorUniversity of Texas Southwestern Medical Center
- Enrollment15
- Start date2012-08-08
- ConditionsRectal Adenocarcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.